Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.875
-0.125 (-6.25%)
Dec 3, 2024, 12:29 PM EST - Market open
Pyxis Oncology Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$10.00
Upside
+433.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $7 → $10 | Buy | Maintains | $7 → $10 | +433.33% | Nov 21, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +273.33% | Nov 21, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $13 | Buy | Initiates | $13 | +593.33% | Nov 8, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | +273.33% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +273.33% | Aug 16, 2024 |
| Stifel | Stifel | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +433.33% | Aug 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +273.33% | May 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +433.33% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +273.33% | Apr 10, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | +273.33% | Mar 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +273.33% | Mar 22, 2024 |
| BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +326.67% | Feb 9, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $12 | Buy | Initiates | $12 | +540.00% | Jan 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +113.33% | Nov 30, 2023 |
| RBC Capital | RBC Capital | Buy Initiates $7 | Buy | Initiates | $7 | +273.33% | Sep 5, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.